BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1131 related articles for article (PubMed ID: 29065451)

  • 1. Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome.
    Hung WC; Ling XH; Chang CC; Hsu HF; Wang SW; Lee YC; Luo C; Lee YT; Houng JY
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29065451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
    Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
    BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant and anti-glycation capacities of some medicinal plants and their potential inhibitory against digestive enzymes related to type 2 diabetes mellitus.
    Franco RR; da Silva Carvalho D; de Moura FBR; Justino AB; Silva HCG; Peixoto LG; Espindola FS
    J Ethnopharmacol; 2018 Apr; 215():140-146. PubMed ID: 29274842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annona muricata Linn. leaf as a source of antioxidant compounds with in vitro antidiabetic and inhibitory potential against α-amylase, α-glucosidase, lipase, non-enzymatic glycation and lipid peroxidation.
    Justino AB; Miranda NC; Franco RR; Martins MM; Silva NMD; Espindola FS
    Biomed Pharmacother; 2018 Apr; 100():83-92. PubMed ID: 29425747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corn silk (Zea mays L.), a source of natural antioxidants with α-amylase, α-glucosidase, advanced glycation and diabetic nephropathy inhibitory activities.
    Wang KJ; Zhao JL
    Biomed Pharmacother; 2019 Feb; 110():510-517. PubMed ID: 30530231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro.
    Ademiluyi AO; Oboh G
    J Basic Clin Physiol Pharmacol; 2012 Jan; 23(1):17-25. PubMed ID: 22865445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some biological activities of Epaltes divaricata L. - an in vitro study.
    Glorybai L; Kannan K B; Arasu MV; Al-Dhabi NA; Agastian P
    Ann Clin Microbiol Antimicrob; 2015 Mar; 14():18. PubMed ID: 25879935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic effects of Syzygium cumini leaves: A non-hemolytic plant with potential against process of oxidation, glycation, inflammation and digestive enzymes catalysis.
    Franco RR; Ribeiro Zabisky LF; Pires de Lima Júnior J; Mota Alves VH; Justino AB; Saraiva AL; Goulart LR; Espindola FS
    J Ethnopharmacol; 2020 Oct; 261():113132. PubMed ID: 32673709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant, α-Glucosidase, and Nitric Oxide Inhibitory Activities of Six Algerian Traditional Medicinal Plant Extracts and
    Hellal K; Maulidiani M; Ismail IS; Tan CP; Abas F
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32164186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory potentials of phenolic-rich extracts from Bridelia ferruginea on two key carbohydrate-metabolizing enzymes and Fe
    Afolabi OB; Oloyede OI; Agunbiade SO
    J Integr Med; 2018 May; 16(3):192-198. PubMed ID: 29706572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia.
    Gulati V; Harding IH; Palombo EA
    BMC Complement Altern Med; 2012 Jun; 12():77. PubMed ID: 22713130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant, α-Amylase and α-Glucosidase Inhibitory Activities and Potential Constituents of
    Quan NV; Xuan TD; Tran HD; Thuy NTD; Trang LT; Huong CT; Andriana Y; Tuyen PT
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30744084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of α-amylase and α-glucosidase inhibitory potential of Zea mays Linnaeus (Poaceae), Stigma maydis aqueous extract: An in vitro assessment.
    Sabiu S; O'Neill FH; Ashafa AOT
    J Ethnopharmacol; 2016 May; 183():1-8. PubMed ID: 26902829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension.
    Kwon YI; Jang HD; Shetty K
    Asia Pac J Clin Nutr; 2006; 15(3):425-32. PubMed ID: 16837437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional supplements modulate fluorescent protein-bound advanced glycation endproducts and digestive enzymes related to type 2 diabetes mellitus.
    Koch ER; Deo P
    BMC Complement Altern Med; 2016 Sep; 16(1):338. PubMed ID: 27585435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of Gynura divaricata (L.) DC extracts as inhibitors of key enzymes relevant for type 2 diabetes and hypertension.
    Wu T; Zhou X; Deng Y; Jing Q; Li M; Yuan L
    J Ethnopharmacol; 2011 Jun; 136(2):305-8. PubMed ID: 21570455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucosidase inhibitory activity and antioxidant activity of flavonoid compound and triterpenoid compound from Agrimonia Pilosa Ledeb.
    Liu X; Zhu L; Tan J; Zhou X; Xiao L; Yang X; Wang B
    BMC Complement Altern Med; 2014 Jan; 14():12. PubMed ID: 24410924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal α-glucosidase and some pancreatic enzymes inhibitory effect of hydroalcholic extract of Moringa stenopetala leaves.
    Toma A; Makonnen E; Mekonnen Y; Debella A; Addisakwattana S
    BMC Complement Altern Med; 2014 Jun; 14():180. PubMed ID: 24890563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavonoids and proanthocyanidins-rich fractions from Eugenia dysenterica fruits and leaves inhibit the formation of advanced glycation end-products and the activities of α-amylase and α-glucosidase.
    Justino AB; Guerra Silva HC; Franco RR; de Oliveira Cavalcante Pimentel I; Silva NF; Saraiva AL; Espindola FS
    J Ethnopharmacol; 2022 Mar; 285():114902. PubMed ID: 34890729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro.
    Ademiluyi AO; Oboh G
    Exp Toxicol Pathol; 2013 Mar; 65(3):305-9. PubMed ID: 22005499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.